Jae Young Joung

Long-term clinical outcomes of moderate hypofractionated proton beam therapy for localized prostate cancer: a single-institution retrospective analysis

To evaluate long-term oncologic outcomes and toxicity of moderate hypofractionated proton beam therapy (PBT) in patients with localized prostate cancer. We retrospectively analyzed 192 patients with localized prostate cancer (cT1–T4N0M0) treated with definitive PBT between 2010 a...